← Back to headlines
Emergent BioSolutions Secures $34.5 Million Vaccine Deal
Emergent BioSolutions has signed a $34.5 million deal for vaccine manufacturing and distribution.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips
1h ago
Anthropic Delays AI Startup IPO to Mid-October Amid Credit Facility Deal
2h ago
Trade Negotiations Stall as U.S. Halts Antitrust Cooperation With Canada
2h ago
Corporate Executives Across Various Sectors Sell Company Stock
2h ago